IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21646
Last updated 2021-07-28
Summary
The purpose of this program is to develop a regional integrated stroke system that identifies, classifies, and treats patients with acute ischemic stroke more rapidly and effectively with reperfusion therapy.
Conditions
- Acute Stroke
- Intracranial Hemorrhages
- Subarachnoid Hemorrhage
Sponsors & Collaborators
- collaborator INDUSTRY
- collaborator INDUSTRY
-
Chiesi Farmaceutici S.p.A.
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Carmelo Graffagnino, MD · Duke University
-
Bradley Kolls, MD · Duke University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2021-04-30
- Completion
- 2021-04-30
Countries
- United States
Study Locations
More Related Trials
-
Trial of a Secondary Stroke Prevention Program
NCT01071408 ·Status: COMPLETED ·Phase: NA
-
Dapsone for Acute Ischemia Stroke Study
NCT01144650 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
NCT06781385 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Feasibility and Safety Study to Evaluate the Neuroprotective Effect of Hemodialysis in Acute Ischemic Stroke
NCT04297345 ·Status: UNKNOWN ·Phase: NA
-
Mild and Rapidly Improving Stroke Study
NCT02072681 ·Status: COMPLETED
-
Transitional Care Program to Improve Risk Factors in Stroke Survivors
NCT06657235 ·Status: RECRUITING ·Phase: NA
-
Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients
NCT02907736 ·Status: WITHDRAWN
-
ReoPro and Retavase to Treat Acute Stroke
NCT00046293 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
NCT00046761 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window
NCT05752916 ·Status: COMPLETED ·Phase: PHASE4
-
Cerebrolysin REGistry Study in Stroke
NCT02541227 ·Status: TERMINATED
-
Study of the Follow-up of Stroke Treated With Anticoagulants
NCT03292575 ·Status: COMPLETED
-
Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy
NCT05700097 ·Status: UNKNOWN ·Phase: PHASE2
-
DNS-3379 vs. Placebo in Stroke Rehabilitation
NCT03254160 ·Status: TERMINATED ·Phase: PHASE2
-
Study on the Efficacy and Safety of T-02 for the Treatment for Acute Ischemic Stroke
NCT05342038 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
NCT00856661 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke
NCT00790920 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke
NCT02730455 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of Biomarkers in Ischemic Stroke - Clinical Trial
NCT04253275 ·Status: COMPLETED ·Phase: NA
-
Biomarkers of Acute Stroke in Clinic
NCT03897478 ·Status: UNKNOWN
-
A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS
NCT07084012 ·Status: RECRUITING ·Phase: PHASE2
-
Induced Hypertension for Acute Ischemic Stroke
NCT00227448 ·Status: COMPLETED ·Phase: PHASE2
-
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
NCT03578822 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Effects of Disease Management Programs for Prevention of Recurrent Ischemic Stroke
NCT02121327 ·Status: COMPLETED ·Phase: NA